Turning first to the implications of our study for APOE and AD, our finding of no difference between PMC Glx, GABA+ and E/I balance in APOE groups could inform the timeline of spatiotemporal evolution of hyperactivity differences in APOE E4 carriers. Here, APOE is linked to Alzheimer disease.